Cabaletta Bio, Inc.
CABA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001759138
No open-market purchases or sales by Cabaletta Bio, Inc. insiders were filed in the last 90 days; 139 institutions reported holding it in 13F filings for Q2 2026, worth $490.4M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Cabaletta Bio, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 142 | 1 | 120 | −21 |
| Shares | 50.8M | 4.76M | 48.0M | +2.00M (+4.4%) |
| Value | $380.0M | $35.6M | $226.7M | −$117.7M (−34.2%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Cabaletta Bio, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 4,793,484 | $22.6M | 0.00% |
| Point72 Asset Management, L.P. | 667,275 | $3.15M | 0.01% |
| Cubist Systematic Strategies, LLC | 573,180 | $2.71M | 0.04% |
| Acadian Asset Management LLC | 257,421 | $1.21M | 0.00% |
| SG Americas Securities, LLC | 35,098 | $166.0K | 0.00% |
| D. E. Shaw & Co., Inc. | 33,963 | $160.3K | 0.00% |
| Gsa Capital Partners LLP | 26,976 | $127.0K | 0.01% |
| Intech Investment Management LLC | 14,204 | $67.0K | 0.00% |
| SEI Investments Co | 12,206 | $57.6K | 0.00% |
| ProShare Advisors LLC | 11,265 | $53.2K | 0.00% |
| JustInvest LLC | 10,173 | $48.0K | 0.00% |
| Point72 (DIFC) Ltd | 6,987 | $33.0K | 0.00% |
| Point72 Asia (Singapore) Pte. Ltd. | 6,680 | $31.5K | 0.01% |
| nVerses Capital, LLC | 3,000 | $14.2K | 0.01% |
| CIBC Private Wealth Group, LLC | 2,000 | $9.44K | 0.00% |
| Truvestments Capital LLC | 766 | $3.62K | 0.00% |
| Federated Hermes, Inc. | 388 | $1.83K | 0.00% |
| Sterling Capital Management LLC | 116 | $548 | 0.00% |
| Northwestern Mutual Wealth Management Co | 93 | $439 | 0.00% |
| Rothschild Investment LLC | 25 | $118 | 0.00% |
Sold out (41)
Institutions that held Cabaletta Bio, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
Not filed for Q3 2024 yet (1)
Institutions that held Cabaletta Bio, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 4,756,219 | $35.6M |